126 related articles for article (PubMed ID: 7576016)
1. Hepatitis C virus infection as a possible risk factor for ductopenic rejection (vanishing bile duct syndrome) after liver transplantation.
Hoffmann RM; Günther C; Diepolder HM; Zachoval R; Eissner HJ; Forst H; Anthuber M; Paumgartner G; Pape GR
Transpl Int; 1995; 8(5):353-9. PubMed ID: 7576016
[TBL] [Abstract][Full Text] [Related]
2. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.
Ontañón J; Muro M; García-Alonso AM; Minguela A; Torío A; Bermejo J; Pons JA; Campos M; Alvarez-López MR
Transplantation; 1998 Apr; 65(8):1047-53. PubMed ID: 9583864
[TBL] [Abstract][Full Text] [Related]
3. Cytomegalovirus infection and donor/recipient HLA antigens: interdependent co-factors in pathogenesis of vanishing bile-duct syndrome after liver transplantation.
O'Grady JG; Alexander GJ; Sutherland S; Donaldson PT; Harvey F; Portmann B; Calne RY; Williams R
Lancet; 1988 Aug; 2(8606):302-5. PubMed ID: 2899720
[TBL] [Abstract][Full Text] [Related]
4. Cytomegalovirus infection does not increase the risk of vanishing bile duct syndrome after liver transplantation.
van den Berg AP; Klompmaker IJ; Hepkema BG; Gouw AS; Haagsma EB; Lems SP; The TH; Slooff MJ
Transpl Int; 1996; 9 Suppl 1():S171-3. PubMed ID: 8959818
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between cytomegalovirus infection, HLA matching and the vanishing bile duct syndrome after liver transplantation.
Paya CV; Wiesner RH; Hermans PE; Larson-Keller JJ; Ilstrup DM; Krom RA; Moore SB; Ludwig J; Smith TF
Hepatology; 1992 Jul; 16(1):66-70. PubMed ID: 1319956
[TBL] [Abstract][Full Text] [Related]
6. The influence of HLA matching on cytomegalovirus hepatitis and chronic rejection after liver transplantation.
Mañez R; White LT; Linden P; Kusne S; Martin M; Kramer D; Demetris AJ; Van Thiel DH; Starzl TE; Duquesnoy RJ
Transplantation; 1993 May; 55(5):1067-71. PubMed ID: 8388584
[TBL] [Abstract][Full Text] [Related]
7. Sex mismatch as a risk factor for chronic rejection of liver allografts.
Candinas D; Gunson BK; Nightingale P; Hubscher S; McMaster P; Neuberger JM
Lancet; 1995 Oct; 346(8983):1117-21. PubMed ID: 7475600
[TBL] [Abstract][Full Text] [Related]
8. Successful treatment of fibrosing cholestatic hepatitis after liver transplantation.
Cimsit B; Assis D; Caldwell C; Arvelakis A; Taddei T; Kulkarni S; Schilsky M; Emre S
Transplant Proc; 2011 Apr; 43(3):905-8. PubMed ID: 21486625
[TBL] [Abstract][Full Text] [Related]
9. Long-term recurrence-free survival after liver transplantation from an ABO-incompatible living donor for treatment of hepatocellular carcinoma exceeding Milano criteria in a patient with hepatitis B virus cirrhosis: a case report.
Nakamura Y; Hama K; Iwamoto H; Yokoyama T; Kihara Y; Konno O; Jojima Y; Shimazu M
Transplant Proc; 2012 Mar; 44(2):565-9. PubMed ID: 22410070
[TBL] [Abstract][Full Text] [Related]
10. CMV hepatitis after liver transplantation: incidence, clinical course, and long-term follow-up.
Seehofer D; Rayes N; Tullius SG; Schmidt CA; Neumann UP; Radke C; Settmacher U; Müller AR; Steinmüller T; Neuhaus P
Liver Transpl; 2002 Dec; 8(12):1138-46. PubMed ID: 12474153
[TBL] [Abstract][Full Text] [Related]
11. Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience.
Ghobrial RM; Farmer DG; Baquerizo A; Colquhoun S; Rosen HR; Yersiz H; Markmann JF; Drazan KE; Holt C; Imagawa D; Goldstein LI; Martin P; Busuttil RW
Ann Surg; 1999 Jun; 229(6):824-31; discussion 831-3. PubMed ID: 10363896
[TBL] [Abstract][Full Text] [Related]
12. Cytokine profile of liver- and blood-derived nonspecific T cells after liver transplantation: T helper cells type 1/0 lymphokines dominate in recurrent hepatitis C virus infection and rejection.
Schirren CA; Jung M; Worzfeld T; Mamin M; Baretton GB; Gruener NH; Gerlach JT; Diepolder HM; Zachoval R; Pape GR
Liver Transpl; 2000 Mar; 6(2):222-8. PubMed ID: 10719024
[TBL] [Abstract][Full Text] [Related]
13. Cytomegalovirus infection after liver transplantation: prophylaxis and preemptive treatment--a single-center experience.
Perrella A; Esposito C; Ioia G; Campanella L; Taglialatela D; Cuomo O
Transplant Proc; 2010 May; 42(4):1226-8. PubMed ID: 20534267
[TBL] [Abstract][Full Text] [Related]
14. [A clinicopathologic study on complications of orthotopic liver transplantation in 54 patients with chronic hepatitis B virus infection].
Pei F; Zheng J; Du J; Zhong HH; Yang JP
Beijing Da Xue Xue Bao Yi Xue Ban; 2008 Aug; 40(4):408-14. PubMed ID: 18677390
[TBL] [Abstract][Full Text] [Related]
15. Living related liver transplantation: histopathologic analysis of graft dysfunction in 304 patients.
Minamiguchi S; Sakurai T; Fujita S; Okuno T; Haga H; Mino M; Kanehira K; Matsushiro H; Nakashima Y; Inomata Y; Tanaka K; Yamabe H
Hum Pathol; 1999 Dec; 30(12):1479-87. PubMed ID: 10667427
[TBL] [Abstract][Full Text] [Related]
16. The influence of cytomegalovirus viraemia on the outcome of recurrent hepatitis C after liver transplantation.
Teixeira R; Pastacaldi S; Davies S; Dhillon AP; Emery VC; Rolles K; Davidson B; Patch D; Burroughs AK
Transplantation; 2000 Nov; 70(10):1454-8. PubMed ID: 11118089
[TBL] [Abstract][Full Text] [Related]
17. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
Donaldson P; Underhill J; Doherty D; Hayllar K; Calne R; Tan KC; O'Grady J; Wight D; Portmann B; Williams R
Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
[TBL] [Abstract][Full Text] [Related]
18. A 10-year experience of liver transplantation for hepatitis C: analysis of factors determining outcome in over 500 patients.
Ghobrial RM; Steadman R; Gornbein J; Lassman C; Holt CD; Chen P; Farmer DG; Yersiz H; Danino N; Collisson E; Baquarizo A; Han SS; Saab S; Goldstein LI; Donovan JA; Esrason K; Busuttil RW
Ann Surg; 2001 Sep; 234(3):384-93; discussion 393-4. PubMed ID: 11524591
[TBL] [Abstract][Full Text] [Related]
19. Association of cytomegalovirus genotype with graft rejection after liver transplantation.
Rosen HR; Corless CL; Rabkin J; Chou S
Transplantation; 1998 Dec; 66(12):1627-31. PubMed ID: 9884250
[TBL] [Abstract][Full Text] [Related]
20. Vanishing bile-duct syndrome following liver transplantation--is it reversible?
Hubscher SG; Buckels JA; Elias E; McMaster P; Neuberger J
Transplantation; 1991 May; 51(5):1004-10. PubMed ID: 1851580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
